[company_age]2.0[/company_age][employees]2-10 employees[/employees][description]Rosetta Omics is a French company that specializes in precision medicine for oncology. They use a multi-omics approach to characterize tumors and identify the best treatment options for patients. Their technology includes mass spectrometry imaging, laser capture microdissection, liquid chromatography coupled to tandem mass spectrometry, and artificial intelligence. Rosetta Omics' mission is to help oncologists, clinicians, and pathologists better diagnose, stratify, and rank first-line treatment options for cancer patients. They believe that their approach can help to improve patient care and reduce the cost of cancer treatment.[/description][ps]Multi-omics tumor characterization, biomarker discovery, drug development[/ps]